GAME vs REGN · rev $96.2M vs P/E 14, rev $14.34B
GameSquare Holdings Inc. (GAME) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
GameSquare Holdings Inc. (GAME) is a electronic gaming & multimedia company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported GAME revenue for 2024-12-31 was $96.2M. Net income was -$54.3M. Revenue was up 132.9% from 2023-12-31 to 2024-12-31. GAME currently screens at market cap $84.5M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
GAME currently screens at market cap $84.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the GAME and REGN stock pages for the full models.
Not investment advice.